PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-19.77%
Negative net income growth while MCHP stands at 10.33%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
7.42%
Some D&A expansion while MCHP is negative at -8.35%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
49.29%
Well above MCHP's 18.91% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
55.88%
SBC growth well above MCHP's 1.37%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-227.14%
Negative yoy working capital usage while MCHP is 110.71%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-38.62%
Both yoy AR lines negative, with MCHP at -22.56%. Martin Whitman would suspect an overall sector lean approach or softer demand.
7.69%
Inventory shrinking or stable vs. MCHP's 93.31%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-670.00%
Both negative yoy AP, with MCHP at -64.35%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-261.98%
Negative yoy usage while MCHP is 1116.13%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-1650.00%
Negative yoy while MCHP is 191.30%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-47.14%
Negative yoy CFO while MCHP is 39.99%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-8.71%
Negative yoy CapEx while MCHP is 1.42%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
6500.00%
Some acquisitions while MCHP is negative at -40.00%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-89.63%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-22.87%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-566.67%
We reduce yoy other investing while MCHP is 22.02%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-970.42%
We reduce yoy invests while MCHP stands at 6.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-57.09%
Both yoy lines negative, with MCHP at -47.57%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
44.44%
We slightly raise equity while MCHP is negative at -45.36%. John Neff sees competitor possibly preserving share count or buying back shares.
95.38%
Repurchase growth above 1.5x MCHP's 48.78%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.